Improving Cell Recycling System to Treat Lysosomal Storage Disease

News   Jul 18, 2017 | Original Story from the NIH NCATS

 
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

The compound methyl-β-cyclodextrin turns on an enzyme, AMPK, triggering a response against a rare genetic disease, NPC1. Credit: NCATS

 
 
 

RELATED ARTICLES

“Nanokicking” Technology Enables Breakthrough in the Culture of 3D Mineralised Bone Tissue

News

Researchers have grown 3D samples of mineralised bone from human mesenchymal stem cells for the first time without typical osteoinductive media.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

APC Protein Deletion Disrupts Cell Signalling and Could Cause Autism

News

Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE